Skip to content

Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

SOCIALBI, a Rasch Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04034875
Enrollment
50
Registered
2019-07-26
Start date
2019-04-09
Completion date
2023-07-28
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Lesion

Keywords

Acquired cerebral lesion, Anger, Aggression

Brief summary

The incidence of aggression and violent behavior is usually reported to be high after acquired brain injury, around 54%. Behaviors with verbal agression and, less frequently, physical agressions, are described. These behaviors may be linked to the dysfunction of the frontal lobes responsible for executive functions and complex social interactions, or to the dysfunction of the temporal structures that may also be responsible for increased aggression. It is interesting to note that very few scales or specific questionnaires evaluate the factors and co-variables that could lead to aggressive behavior after an acquired brain injury. Such questionnaires are very rare, and none have been validated in French. The objective of this study is to develop a questionnaire in French that aims to assess anger, hostility and aggression after acquired brain injury. The psychometric qualities of this questionnaire will be evaluated using the Rasch probabilistic model. The development of such a tool will be of major interest for clinical practice and future clinical research.

Interventions

OTHERQuestionnaire

questionnaire

Sponsors

Brugmann University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients of the CHU Brugmann Hospital * Central neurological pathology of vascular or traumatic origin, acute or chronic (known since more than one year).

Exclusion criteria

* Pregnant or lactating women * Presence or antecedents of psychiatric disease * Degenerative pathology (ex: Parkinson...) * Antecedents of other neurologic pathologies before the acquired lesion * Oral or written comprehension dysfunctions.

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire evaluation by Rasch methodology30 minutesquestionnaire validity

Countries

Belgium, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026